Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
申请人:Brockunier L. Linda
公开号:US20050107390A1
公开(公告)日:2005-05-19
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
本发明涉及一种双肽酶-IV酶(DP-IV酶)抑制剂化合物,该化合物在治疗或预防涉及DP-IV酶的疾病中具有用途,例如糖尿病,特别是2型糖尿病。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗涉及DP-IV酶的这些疾病中使用这些化合物和组合物的用途。